Sensitivity decreased from 0.91 on a balanced refinement dataset to 0.62 on an independent dataset reflecting real-world prevalence
THURSDAY, Jan. 15, 2026 (HealthDay News) — A fully autonomous artificial intelligence (AI) model can screen for cognitive impairment from clinical notes, according to a study published online Jan. 7 in npj Digital Medicine.
Jiazi Tian, from Massachusetts General Hospital in Boston, and colleagues developed two large language model workflows for identifying cognitive concerns from clinical notes: an expert-driven workflow with iterative prompt refinement across three large language models and an autonomous agentic workflow coordinating five specialized agents for prompt optimization. The model was optimized on a balanced refinement dataset and validated on an independent dataset, which reflected real-world prevalence.
The researchers found that relative to the expert-driven workflow, the agentic workflow achieved comparable validation performance (F1: 0.74 versus 0.81) and superior refinement results (0.93 versus 0.87). Sensitivity decreased from 0.91 in the refinement dataset to 0.62 in the independent dataset, demonstrating the impact of a shift in prevalence on generalizability. In expert readjudication, the agentic workflow was clinically correct in seven of 16 false-negative cases (44 percent), reflecting clinically appropriate reasoning.
“We didn”t build a single AI model — we built a digital clinical team,” coauthor Hossein Estiri, Ph.D., also from Massachusetts General Hospital, said in a statement. “This AI system includes five specialized agents that critique each other and refine their reasoning, just like clinicians would in a case conference.”
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints
Retinal Imaging Can ID Atrial Fibrillation Years Before Diagnosis
U.S. Adults May Not Understand Their Risk for Vascular Disease
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk
Nearly 1 in 10 Older Adults Used Cannabis in the Past Year
Polypharmacy of Prescription Medications Increased for U.S. Older Adults
Lower Vertebral Bone Mineral Density Linked to Cognitive Decline